news & events
portfolio news
05.03.21
ONA Therapeutics appoints Mark Throsby to its Board of Directors
17.02.21
New Data Supports High Reperfusion Rate for Anaconda Biomed’s Mechanical Thrombectomy System
10.02.21
Sanifit Granted Orphan Drug Designation by the FDA for SNF472 for the Treatment of Peripheral Arterial Disease in Patients with End-stage Kidney Disease
10.02.21
MedLumics closes upsized EUR 18M (21.7M USD) financing round and appoints new Chairman
09.02.21
CorWave Joins the French Tech 120 Index, a Community That Brings Together the Top French Tech Scale-up Companies
04.02.21
Dr Daniel C. Chung appointed as Chief Medical Officer of SparingVision
29.01.21
Renowned Pioneers in Ophthalmology Join SparingVision’s Scientific Advisory Board
27.01.21
VarmX appoints Dr. Gerard Short as Chief Medical Officer
26.01.21
Minoryx presents topline results from Phase 2/3 “ADVANCE” study demonstrating significant clinical benefit of leriglitazone in adrenomyeloneuropathy (AMN)
21.01.21
Inbiomotion raises an oversubscribed financing round to launch its diagnostic product in breast cancer
